Literature DB >> 1280883

Histopathology of myoepithelial (basocellular) hyperplasias in adenosis and epitheliosis of the breast demonstrated by the reactivity of cytokeratins and S100 protein. An analysis of heterogenic cell proliferations in 90 cases of benign and malignant breast diseases.

R Bässler1, B Katzer.   

Abstract

This study on the different types of epithelial hyperplasia in fibrocystic disease was inspired by the observation of myoepithelial (basocellular) hyperplasia identified by strong expression of S100 protein and a weak reaction with antibodies against cytokeratin (KL1) in cells forming solid and acinar buds. The cells do not contain immunohistochemically detectable actin or desmin. Glandular transformation and proliferation give rise to basocellular circumductal adenosis. Normal breast tissue, 51 cases of fibrocystic disease with mild, florid and atypical hyperplasias, 7 fibroadenomas and 20 cases of carcinoma in situ were studied and a semiquantitative analysis revealed basal buds and adenosis in less than 40% of cases of mild hyperplasia and up to 73% in florid hyperplasia. Epitheliosis is characterized by a heterogeneous cell pattern with cells positive for S100 protein in 30-60%, but in small ducts up to 100% with an immediate connection to the basal cell layer were positive. Carcinoma in situ contained very rare tumour cells positive for S100 protein. The cells expressing S100 protein in terminal ducts, in adenosis and epitheliosis showed only some of the characteristics of myoepithelial cells, since they lack immunoreactivity with antibodies against actin. These basal clear cells are interpreted as transitional or indeterminate cells with features of myoepithelial precursor cells, but with the ability to develop basocellular nodular and glandular hyperplasia in the ductulo-lobular units in cases of adenosis and juvenile fibroadenoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280883     DOI: 10.1007/BF01606917

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  49 in total

1.  [Epithelial tumor markers].

Authors:  R Moll
Journal:  Verh Dtsch Ges Pathol       Date:  1986

2.  Various expressions of modified myoepithelial cells in salivary pleomorphic adenoma. Immunohistochemical studies.

Authors:  M Mori; K Tsukitani; T Ninomiya; Y Okada
Journal:  Pathol Res Pract       Date:  1987-10       Impact factor: 3.250

3.  Cell proliferation in the human mammary epithelium. Differential contribution by epithelial and myoepithelial cells.

Authors:  K Joshi; J A Smith; N Perusinghe; P Monoghan
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

Review 4.  The myothelia (myoepithelial cells). Normal state; regressive changes; hyperplasia; tumors.

Authors:  H Hamperl
Journal:  Curr Top Pathol       Date:  1970

5.  Ultrastructure of myoepithelial cells in human mammary gland tumors.

Authors:  T M Murad; E Von Haam
Journal:  Cancer       Date:  1968-06       Impact factor: 6.860

6.  Immunohistochemical localization of S100 protein in benign and malignant conditions of the breast.

Authors:  M J Egan; J Newman; J Crocker; M Collard
Journal:  Arch Pathol Lab Med       Date:  1987-01       Impact factor: 5.534

7.  Epitheliosis of the breast. An immunohistochemical characterization and comparison to malignant intraductal proliferations of the breast.

Authors:  U Raju; J D Crissman; R J Zarbo; C Gottlieb
Journal:  Am J Surg Pathol       Date:  1990-10       Impact factor: 6.394

8.  A possible mammary stem cell line.

Authors:  D C Bennett; L A Peachey; H Durbin; P S Rudland
Journal:  Cell       Date:  1978-09       Impact factor: 41.582

Review 9.  Ultrastructure of the human breast and its disorders.

Authors:  E R Fisher
Journal:  Am J Clin Pathol       Date:  1976-08       Impact factor: 2.493

10.  Dual secretory and myoepithelial differentiation in the transplantable R3230AC rat mammary carcinoma.

Authors:  M Papotti; R Coda; A Ottinetti; G Bussolati
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.